Bayzed Health Group, Inc. engages in the provision of investment, medical, and healthcare services. The company is headquartered in Beijing, Beijing and currently employs 2,105 full-time employees. The company went IPO on 2025-06-23. The firm provides services in the field of full-cycle medical services for tumors, including screening, diagnosis, treatment and rehabilitation. The firm is principally engaged in hospital business, hospital management services, supply of pharmaceuticals, medical equipment and consumables and other businesses. The firm's business also includes tumor diagnosis, tumor treatment, tumor rehabilitation and hospice care for patients, as well as early cancer screening, tumor vaccination and health management services for other potential healthy people. The firm mainly operates its businesses in China market.
02609.HK stock price ended at $3.49 on 金曜日, after rising 3.25%
On the latest trading day Feb 13, 2026, the stock price of 02609.HK rose by 3.25%, climbing from $3.45 to $3.49. Throughout the session, the stock experienced a volatility of 5.97%, with prices fluctuating between a daily low of $3.35 and a high of $3.55. Alongside this price increase, trading volume also rose by 511.4K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 2.2M shares were traded, amounting to a market value of approximately $4.6B.